atezolizumab
antiantibody
lucatumumab
lymphadenomatous
mogamulizumab
dorlixizumab
lymphodeplete
antilymphangiogenic
lymphographic
cyclophosphamide
lymphocytolytic
nofetumomab
lymphogram
afutuzumab
leucocrit
lymphangial
teplizumab
tenatumomab
amivantamab
patritumab
lymphomatogenesis
hematogone
milatuzumab
edrecolomab
lymphoepithelium
amatuximab
panitumumab
-lim-
lymphadenia
lymphoplasmacytoid
inotuzumab ozogamicin
drozitumab
intralymphocytic
diffuse large B-cell lymphoma
MALT lymphoma
-mab
loncastuximab tesirine
lymphocytopoietic
MALToma
lymphopenic
monoantibody
angioimmunoblastic
zalutumumab
lymphocytic
lymphangiographically
defense mechanism
ensituximab
Waldenström's macroglobulinemia
lymphosufficient
lymphoplasmacellular